Robotic implementation of a microchip-based protein clean-up and enrichment system for MALDI-TOF MS readout

Measurement Science and Technology

Volumn 17, Issue 12, 2006, Pages 3147-3153

  Wallman, Lars ^a   Ekström, Simon ^a   Magnusson, Mattias ^a   Bolmsjö, Gunnar ^a   Olsson, Magnus ^a   Nilsson, Johan ^a   Marko Varga, György ^a,b   Laurell, Thomas ^a  

^a LUND UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Automation; Capillary force; MALDI; MALDI TOF MS; Mass spectrometry; Microchip; Microfluidics; Piezodispensing; Protein analysis; Proteomics; Robotic; Solid phase extraction

Indexed keywords

AUTOMATION; CAPILLARY FLOW; EXTRACTION; MASS SPECTROMETRY; MICROELECTRONICS; PROTEINS; ROBOTICS;

CAPILLARY FORCE; MALDI-TOF MS; MICROFLUIDICS; PIEZODISPENSING; PROTEIN ANALYSIS; SOLID PHASE EXTRACTION;

FLUIDICS;

AUTOMATION; CAPILLARY FLOW; EXTRACTION; FLUIDICS; MASS SPECTROMETRY; MICROELECTRONICS; PROTEINS; ROBOTICS;

EID: 33846110953     PISSN: 09570233     EISSN: 13616501     Source Type: Journal    
DOI: 10.1088/0957-0233/17/12/S05     Document Type: Article

References (26)

1. Marko-Varga G, Lindberg H, Löfdahl C-G, Jönsson P, Hansson L, Dahlbäck M, Lindquist E, Johansson L, Foster M and Fehniger T E 2005 Discovery of biomarker candidates within disease by protein profiling: principles and concepts J. Proteome Res. 4 1200-12
2. Patterson S D 2003 Data analysis-the Achilles heel of proteomics Nat. Biotechnol. 21 221-2
3. Araki J, Okamoto I, Suto R, Ichikawa Y and Sasaki J 2005 Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer Lung Cancer 48 141-4
4. Takano T et al 2004 Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib Lung Cancer 45 93-104
5. Omenn G S 2004 Advancement of biomarker discovery and validation through the HUPO plasma proteome project Discovery Markers 20 131-4
6. Omenn G S 2004 The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses Proteomics 4 1235-40
7. Zolg J W and Langen H 2004 How industry is approaching the search for new diagnostic markers and biomarkers Mol. Cell. Proteomics 3 345-54
8. Branca M A 2005 Gene therapy: cursed or inching towards credibility? Nat. Biotechnol. 23 519-21
9. Ebersole T J, Guthrie M C and Goldstein J A 2005 Patent pools and standard setting in diagnostic genetics Nat. Biotechnol. 23 937-8
10. Taube S E, Jacobsen J W and Lively T G 2005 Cancer diagnostics: decision criteria for marker utilization in the clinic Am. J. Pharmcogenomics 5 357-64
11. Jacobs J M, Adkins J N, Qian W-J, Liu T, Shen Y, Camp D G II and R D Smith 2005 Utilizing human blood plasma for proteomic biomarker discovery J. Proteome Res. 4 1073-85
12. Wu S-L, Kim J, Hancock W S and Karger B 2005 Extended range proteomic analysis (ERPA): a new sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications- comprehensive analysis of beta-casein and epidermal growth factor receptor J. Proteome Res. 4 1155-70
13. Olsen J V, de Godoy L M F, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S and Mann M 2005 Parts per million mass accuracy on an orbitrap mass spectrometer via lock mass injection into a C-trap Mol. Cell. Proteomics 4 2010-21
14. Yates J R, Cociorva D, Liao L and Zabrouskov V 2006 Performance of a linear ion trap-Orbitrap hybrid for peptide analysis Anal. Chem. 78 493-500
15. Annan R S, Mculty D E and Carr S A 1996 Proc. 44th ASMS Conf. on Mass Spectrometry and Allied Topics (Portland, OR, 1996) p 702
16. Kussmann M et al 1997 Matrix-assisted laser desorption/ionization mass spectrometry sample preparation techniques designed for various peptide and protein analytes. J. Mass Spectrom. 32 593-601
17. Rappsilber J, Ishihama Y and Mann M 2003 Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics Anal. Chem. 75 663-70
18. Pluskal M G 2000 Microscale sample preparation-the demand for microscale analysis has stimulated the development of new solid phase formats in sample preparation Nat. Biotechnol. 18 104-5
19. Xu Y, Bruening M L and Watson J T 2003 Non-specific, on-probe cleanup methods for MALDI-MS samples Mass Spectrom. Rev. 22 429-40
20. Tang N, Tornatore P and Weinberger S R 2004 Current developments in SELDI affinity technology. Mass Spectrom. Rev. 23 34-44
21. Gustafsson M, Hirschberg D, Palmberg C, Jornvall H and Bergman T 2004 Integrated sample preparation and MALDI mass spectrometry on a microfluidic compact disk Anal. Chem. 76 345-50
22. Laurell T, Wallman L and Nilsson J 1999 Design and development of a silicon microfabricated flow-through cell for on-line picolitre sample handling J. Micromech. Microeng. 9 369-76
23. nnerfjord P, Nilsson J, Laurell T and Marko-Varga G 1998 Picoliter sample preparation in MALDI-TOF-MS using a micromachined silicon flow-through dispenser Anal. Chem. 70 4755-60
24. Ekström S, Ericsson D, nnerfjord P, Bengtsson M, Nilsson J, Marko-Varga G and Laurell T 2001 Signal amplification using "spot-on-a- chip" technology for the identification of proteins via MALDI-TOF MS Anal. Chem. 73 214-9
25. Bergqvist J, Ekström S, Wallman L, Löfgren M, Marko-Varga G, Nilsson J and Laurell T 2002 Improved chip design for integrated solid-phase microextraction in on-line proteomic sample preparation Proteomics 2 422-9
26. Wallman L, Ekström S, Marko-Varga G, Laurell T and Nilsson J 2004 Autonomus protein sample processing on-chip using solid-phase microextraction, capillary force pumping, and microdispensing Electrophoresis 25 3778-87